Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
Miyake M et al. The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies. 1990 Cancer pmid:2153431
Nakamura K et al. Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. 1990 J. Biochem. pmid:2332419
Baba H et al. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. 1989 J. Neuroimmunol. pmid:2584393
Singer HS and Cork LC Canine GM2 gangliosidosis: morphological and biochemical analysis. 1989 Vet. Pathol. pmid:2540585
Livingston PO et al. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. 1989 Cancer Res. pmid:2582446
Zvezdina ND et al. Gangliosides of sea urchin embryos. Their localization and participation in early development. 1989 Eur. J. Biochem. pmid:2598928
Vrionis FD et al. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. 1989 Cancer Res. pmid:2479468
Ghidoni R et al. Metabolism of exogenous gangliosides in cerebellar granule cells, differentiated in culture. 1989 J. Neurochem. pmid:2795018
Dotta F et al. Ganglioside expression in human pancreatic islets. 1989 Diabetes pmid:2695376
Fredman P et al. A new ganglioside of the lactotetraose series, GalNAc-3'-isoLM1, detected in human meconium. 1989 J. Biol. Chem. pmid:2473071
Schröder M et al. Isolation of a cDNA encoding the human GM2 activator protein. 1989 FEBS Lett. pmid:2753159
DeGasperi R et al. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus). 1989 Biochem. J. pmid:2527497
Hoon DS et al. Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells. 1989 Int. J. Cancer pmid:2714890
Riboni L et al. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b. 1989 J. Neurochem. pmid:2709011
Walton KM and Schnaar RL Coordinate regulation of ganglioside glycosyltransferases in differentiating NG108-15 neuroblastoma x glioma cells. 1989 J. Neurochem. pmid:2540274
Hechtman P et al. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese. 1989 Clin. Genet. pmid:2527097
Irie RF et al. Human monoclonal antibody to ganglioside GM2 for melanoma treatment. 1989 Lancet pmid:2564593
Paw BH et al. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2522660
Ilyas AA et al. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. 1988 J. Biol. Chem. pmid:2450092
Sanai Y et al. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc). 1988 Biochim. Biophys. Acta pmid:2449247
Jolivet-Reynaud C et al. Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2. 1988 Arch. Biochem. Biophys. pmid:3162668
Kushi Y et al. Direct analysis of glycolipids on thin-layer plates by matrix-assisted secondary ion mass spectrometry: application for glycolipid storage disorders. 1988 Anal. Biochem. pmid:3149874
Miyake M et al. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. 1988 Cancer Res. pmid:3167861
Tanaka A et al. GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. 1988 Biochem. Biophys. Res. Commun. pmid:2973311
Lichtenberg P et al. Post-partum psychosis in adult GM2 gangliosidosis. A case report. 1988 Br J Psychiatry pmid:2977954
Budde-Steffen C et al. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis. 1988 Neuropediatrics pmid:2967444
Torres BV et al. Glycolipid-lectin interactions: reactivity of lectins from Helix pomatia, Wisteria floribunda, and Dolichos biflorus with glycolipids containing N-acetylgalactosamine. 1988 Arch. Biochem. Biophys. pmid:3355161
Naoi M et al. Specific binding of glycosylated beta-galactosidase to rat clonal pheochromocytoma PC12h cells: effects of nerve growth factor and gangliosides. 1988 J. Neurochem. pmid:3126266
DeGasperi R et al. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus). 1988 J. Biol. Chem. pmid:2961751
Ohno K and Suzuki K Mutation in GM2-gangliosidosis B1 variant. 1988 J. Neurochem. pmid:2961848
Ishikawa Y et al. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. 1987 J. Neurochem. pmid:2949061
Li YT et al. Occurrence of ceramide-glycanase in the earthworm, Lumbricus terrestris. 1987 Biochem. Biophys. Res. Commun. pmid:3689409
Nagai K and Ishizuka I Biosynthesis of monosulfogangliotriaosylceramide and GM2 by N-acetylgalactosaminyltransferase from rat brain. 1987 J. Biochem. pmid:3115968
Naoi M et al. Ganglioside GM1 causes expression of type B monoamine oxidase in a rat clonal pheochromocytoma cell line, PC12h. 1987 J. Neurochem. pmid:3117976
Rosengren B et al. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease? 1987 J. Neurochem. pmid:3612128
Eto Y et al. Partial deficiency of beta-hexosaminidase activity in canine GM2-gangliosidosis. 1987 Tohoku J. Exp. Med. pmid:2958961
Yamanaka T et al. Detection of gangliotriaose-series glycosphingolipids in serum of cord blood and patients with neuroblastoma by a sensitive TLC/enzyme-immunostaining method. 1987 Biochim. Biophys. Acta pmid:3300782
Ando I et al. Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells. 1987 Int. J. Cancer pmid:3596830
Yanagisawa K et al. Purification and properties of GM2 synthase, UDP-N-acetylgalactosamine: GM3 beta-N-acetylgalactosaminyltransferase from rat liver. 1987 Biochim. Biophys. Acta pmid:3109491
Harding AE et al. Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: another hexosaminidase A deficiency syndrome. 1987 J. Neurol. Neurosurg. Psychiatry pmid:2956362
Livingston PO et al. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. 1987 Proc. Natl. Acad. Sci. U.S.A. pmid:3472242
Livingston PO et al. Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells. 1987 J. Immunol. pmid:3805726
Dawson G et al. Regulation of GM2 ganglioside metabolism in cultured cells. 1986 Chem. Phys. Lipids pmid:3549015
Wynn CH and Robson B Calculation of the conformation of glycosphingolipids. 2. GM1- and GM2-gangliosides. 1986 J. Theor. Biol. pmid:3626589
Sugimoto M et al. Total synthesis of gangliosides GM1 and GM2. 1986 Carbohydr. Res. pmid:3815403
Natoli EJ et al. A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. 1986 Cancer Res. pmid:3731079
Cavaillon JM et al. Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin. 1986 J. Leukoc. Biol. pmid:2872258
Zeigler M and Bach G Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV. 1986 Clin. Chim. Acta pmid:3087662
Charrow J and Binns HJ Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses. 1986 Clin. Chim. Acta pmid:2938852
Kotagal S et al. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics. 1986 Neurology pmid:3081832
Dahiya R and Brasitus TA Glycosphingolipid patterns of fetal and adult small intestinal mucosa in the sheep. 1986 Biochim. Biophys. Acta pmid:3942764
Kotagal S Diagnosis of AB variant, GM2 gangliosidosis. 1986 Ann. Neurol. pmid:3080943
Miyagi T and Tsuiki S Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane. 1986 FEBS Lett. pmid:3758350
Oates CE et al. Movement disorders associated with chronic GM2 gangliosidosis. Case report and review of the literature. 1986 Eur. Neurol. pmid:3081350
Berry-Kravis E and Dawson G Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor. 1985 J. Neurochem. pmid:2997394
Raghavan SS et al. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures. 1985 Am. J. Hum. Genet. pmid:2934978
Ishizuka I et al. Preparation and enzymatic degradation of monosulfogangliotriaosylceramide. 1985 J. Biol. Chem. pmid:3928630
Sasaki T Glycolipid-binding proteins. 1985 Chem. Phys. Lipids pmid:4064224
Higashi H et al. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. 1985 Cancer Res. pmid:3874688
Iwamori M et al. Brain gangliosides of quaking and shiverer mutants: qualitative and quantitative changes of monosialogangliosides in the quaking brain. 1985 J. Neurochem. pmid:3998734
Kytzia HJ and Sandhoff K Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. 1985 J. Biol. Chem. pmid:3158659
Kasai N et al. Preparation and specificity of avian anti-GM2(NeuGc) ganglioside antiserum. 1985 Biochem. Biophys. Res. Commun. pmid:3925943
Sonderfeld S et al. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects. 1985 Eur. J. Biochem. pmid:3922757
Raghavan S et al. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis. 1985 Biochim. Biophys. Acta pmid:3995063
Burg J et al. Mapping of the gene coding for the human GM2 activator protein to chromosome 5. 1985 Ann. Hum. Genet. pmid:3865618
Navon R et al. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A. 1985 Am. J. Hum. Genet. pmid:3156493
Wenger DA Diagnosis of atypical patients with lipid storage diseases. 1985 Brain Dev. pmid:4014607
Li SC et al. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. 1985 J. Biol. Chem. pmid:2981875
Wood PA et al. Fluorescence polarization analysis, lipid composition, and Na+, K+-ATPase kinetics of synaptosomal membranes in feline GM1 and GM2 gangliosidosis. 1985 J. Neurochem. pmid:2983023
Seyfried TN et al. Cellular distribution of gangliosides in the developing mouse cerebellum: analysis using the staggerer mutant. 1984 J. Neurochem. pmid:6470710
Sandhoff K and Conzelmann E The biochemical basis of gangliosidoses. 1984 Neuropediatrics pmid:6242704
Goebel HH Morphology of the gangliosidoses. 1984 Neuropediatrics pmid:6100800
Di Gregorio F et al. The influence of gangliosides on neurite growth and regeneration. 1984 Neuropediatrics pmid:6100799
Pampiglione G and Harden A Neurophysiological investigations in GM1 and GM2 gangliosidoses. 1984 Neuropediatrics pmid:6100798
Schulte FJ Clinical course of GM2 gangliosidoses. A correlative attempt. 1984 Neuropediatrics pmid:6100797
Li YT et al. Isolation and characterization of a novel phytosphingosine-containing GM2 ganglioside from mullet roe (Mugil cephalus). 1984 J. Biol. Chem. pmid:6746635
Schwab ME and Vassella F Synopsis: gangliosidoses. 1984 Neuropediatrics pmid:6100793
Meek D et al. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. 1984 Ann. Neurol. pmid:6430210
Scheideler MA et al. Cell-cycle dependence of a ganglioside glycosyltransferase activity and its inhibition by enkephalin in a neurotumor cell line. 1984 J. Neurochem. pmid:6422000
Itoh H et al. The fine structure of cytoplasmic inclusions in brain and other visceral organs in Sandhoff disease. 1984 Brain Dev. pmid:6097133
Kadowaki H et al. Separation of brain monosialoganglioside molecular species by high-performance liquid chromatography. 1984 J. Lipid Res. pmid:6512419
Fishman PH et al. The role of gangliosides in the interaction of human chorionic gonadotropin and cholera toxin with murine Leydig tumor cells. 1984 J. Biol. Chem. pmid:6330091
Li SC et al. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2. 1984 J. Biol. Chem. pmid:6232275
Nojiri H et al. Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60. 1984 Blood pmid:6589019
Yu RK et al. Characterization of some minor gangliosides in Tay-Sachs brains. 1983 Brain Res. pmid:6414648
Kniep B et al. Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's disease. 1983 J. Immunol. pmid:6886427
Conzelmann E et al. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. 1983 Am. J. Hum. Genet. pmid:6614006
Tai T et al. Ganglioside GM2 as a human tumor antigen (OFA-I-1). 1983 Proc. Natl. Acad. Sci. U.S.A. pmid:6193515
Yusuf HK et al. Ganglioside biosynthesis in Golgi apparatus of rat liver. Stimulation by phosphatidylglycerol and inhibition by tunicamycin. 1983 Eur. J. Biochem. pmid:6861762
Inui K et al. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. 1983 Am. J. Hum. Genet. pmid:6224417
Li YT et al. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates. 1983 Am. J. Hum. Genet. pmid:6222647
Hashimoto Y et al. Genetic regulation of GM2 expression in liver of mouse. 1983 J. Biochem. pmid:6874670
Kaplan F and Hechtman P Purification and properties of two enzymes catalyzing galactose transfer to GM2 ganglioside from rat liver Golgi. 1983 J. Biol. Chem. pmid:6401719
Hirabayashi Y et al. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis. 1983 J. Neurochem. pmid:6848657
Young WW et al. Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy. 1983 J. Exp. Med. pmid:6848617
Harzer K Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses. 1983 Clin. Chim. Acta pmid:6228344
Watanabe T et al. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. 1982 J. Exp. Med. pmid:7175442
Hasilik A et al. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. 1982 Eur. J. Biochem. pmid:6214395
Poulos A et al. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate. 1982 Clin. Chim. Acta pmid:6210469
Conzelmann E et al. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. 1982 Eur. J. Biochem. pmid:6210531